Sympathetic activation and malignant ventricular arrhythmias: a molecular link?

captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects. Int J Cardiol 1994; 43: 43–50. [12] Gibson CM. A union in reperfusion: the concept of facilitated percutaneous coronary intervention. J Am Coll Cardiol 2000; 36: 1497–9. [13] Herrmann HC, Moliterno DJ, Ohman EM et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 2000; 36: 1489–96. [14] Montalescot G, Barragan P, Wittenberg O et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895– 903. [15] Le May MR, Labinaz M, Davies RF et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001; 37: 985–91. [16] Antoniucci D, Valenti R, Moschi G et al. Primary stenting in nonselected patients with acute myocardial infarction: the Multilink Duet in Acute Myocardial Infarction (MIAMI) trial. Catheter Cardiovasc Interv 2000; 51: 273–9. [17] Belli G, Pezzano A, De Biase AM et al. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2000; 50: 362–70.